Conclusion
T-ALL is a type of blood cancer that is neither contagious nor inherited. It affects T-cells, which are important to protect the body against infections, and has a few key genetic alterations we can find in the bone marrow and the cancer cells. Signs and symptoms are similar to those found in other types of leukemia and include a fever of unknown origin, increased frequency of infections, fatigue, anemia, bleeding and bruising. Treatment options are usually aggressive from the start to prevent relapse and include a multimodal therapy of chemotherapy, radiotherapy, and stem cell transplantation in high-risk cases.
References
Marks, D. I., & Rowntree, C. (2017). Management of adults with T-cell lymphoblastic leukemia. Blood, The Journal of the American Society of Hematology, 129(9), 1134-1142.
Vadillo, E., Dorantes-Acosta, E., Pelayo, R., & Schnoor, M. (2018). T cell acute lymphoblastic leukemia (T-ALL): new insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies. Blood reviews, 32(1), 36-51.
Follini, E., Marchesini, M., & Roti, G. (2019). Strategies to overcome resistance mechanisms in T-cell acute lymphoblastic leukemia. International journal of molecular sciences, 20(12), 3021.
Chiaretti, S., & Foà, R. (2009). T-cell acute lymphoblastic leukemia.